BNP Paribas Financial Markets’s Y-mAbs Therapeutics YMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$426K Sell
94,383
-1,119
-1% -$5.05K ﹤0.01% 2654
2025
Q1
$423K Buy
95,502
+90,628
+1,859% +$401K ﹤0.01% 2484
2024
Q4
$38.2K Sell
4,874
-21,545
-82% -$169K ﹤0.01% 3684
2024
Q3
$347K Sell
26,419
-537
-2% -$7.06K ﹤0.01% 2303
2024
Q2
$326K Sell
26,956
-7,919
-23% -$95.7K ﹤0.01% 2219
2024
Q1
$567K Sell
34,875
-299
-0.9% -$4.86K ﹤0.01% 2145
2023
Q4
$240K Buy
35,174
+21,681
+161% +$148K ﹤0.01% 2432
2023
Q3
$73.5K Buy
13,493
+3,896
+41% +$21.2K ﹤0.01% 2718
2023
Q2
$65.2K Sell
9,597
-25,907
-73% -$176K ﹤0.01% 2776
2023
Q1
$178K Buy
35,504
+1,108
+3% +$5.55K ﹤0.01% 2561
2022
Q4
$168K Sell
34,396
-4,615
-12% -$22.5K ﹤0.01% 2417
2022
Q3
$563K Buy
39,011
+31,031
+389% +$447K ﹤0.01% 2246
2022
Q2
$121K Buy
7,980
+5,052
+173% +$76.4K ﹤0.01% 2660
2022
Q1
$34.8K Sell
2,928
-6,172
-68% -$73.3K ﹤0.01% 3053
2021
Q4
$148K Buy
9,100
+2,651
+41% +$43K ﹤0.01% 2845
2021
Q3
$184K Buy
6,449
+4,921
+322% +$140K ﹤0.01% 2481
2021
Q2
$51.6K Sell
1,528
-8,737
-85% -$295K ﹤0.01% 2658
2021
Q1
$310K Sell
10,265
-57,640
-85% -$1.74M ﹤0.01% 2295
2020
Q4
$3.36M Buy
67,905
+60,856
+863% +$3.01M 0.01% 926
2020
Q3
$271K Buy
7,049
+4,912
+230% +$189K ﹤0.01% 1992
2020
Q2
$92.3K Sell
2,137
-8,198
-79% -$354K ﹤0.01% 2181
2020
Q1
$270K Buy
10,335
+7,591
+277% +$198K ﹤0.01% 2128
2019
Q4
$85.8K Sell
2,744
-64
-2% -$2K ﹤0.01% 2701
2019
Q3
$73.2K Buy
2,808
+1,953
+228% +$50.9K ﹤0.01% 2660
2019
Q2
$19.6K Sell
855
-592
-41% -$13.5K ﹤0.01% 3281
2019
Q1
$37.9K Buy
+1,447
New +$37.9K ﹤0.01% 3072